New blood test aims to cut unnecessary prostate biopsies
NCT ID NCT07454603
First seen Mar 07, 2026 · Last updated May 12, 2026 · Updated 5 times
Summary
This study will test a new blood test called PROSTest in 1,500 men who are scheduled for a prostate biopsy due to high PSA levels or abnormal exams. The goal is to see if the blood test can accurately tell who has prostate cancer and who doesn't, potentially helping many men avoid an unnecessary biopsy. Researchers will compare the blood test results with the actual biopsy findings to measure its accuracy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wren Laboratories
Branford, Connecticut, 06405, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.